Literature DB >> 8435204

Psychiatric disorder in patients with advanced breast cancer: prevalence and associated factors.

K L Pinder1, A J Ramírez, M E Black, M A Richards, W M Gregory, R D Rubens.   

Abstract

The prevalence of psychiatric disorder and associated factors has been examined in 139 women with advanced breast cancer. Patients completed a self-report assessment of mood, the Hospital Anxiety and Depression Scale (HAD). They were also interviewed to obtain sociodemographic details, UICC performance status and past psychiatric history. Overall, 35 (25%) scored 11 or above (out of a maximum of 21) on either the anxiety or the depression subscales, or both, of the HAD and were therefore probable cases of anxiety and/or depression. These patients are likely to benefit from psychosocial intervention. Clinical anxiety was unrelated to any sociodemographic or disease related factors. Clinical depression was significantly more prevalent amongst patients in the lower socioeconomic classes (P = 0.01) and those with poor performance status (P = 0.007). Depression can be difficult to detect in patients with advanced breast cancer and these factors may be useful indicators to clinicians of patients at high risk of this disorder.

Entities:  

Mesh:

Year:  1993        PMID: 8435204     DOI: 10.1016/s0959-8049(05)80144-3

Source DB:  PubMed          Journal:  Eur J Cancer        ISSN: 0959-8049            Impact factor:   9.162


  20 in total

1.  Psychosocial sequelae of breast cancer and its treatment.

Authors:  A Moyer; P Salovey
Journal:  Ann Behav Med       Date:  1996-06

2.  Identification of distinct depressive symptom trajectories in women following surgery for breast cancer.

Authors:  Laura B Dunn; Bruce A Cooper; John Neuhaus; Claudia West; Steven Paul; Bradley Aouizerat; Gary Abrams; Janet Edrington; Debby Hamolsky; Christine Miaskowski
Journal:  Health Psychol       Date:  2011-07-04       Impact factor: 4.267

3.  Psychiatric disorders and mental health service use in patients with advanced cancer: a report from the coping with cancer study.

Authors:  Nina S Kadan-Lottick; Lauren C Vanderwerker; Susan D Block; Baohui Zhang; Holly G Prigerson
Journal:  Cancer       Date:  2005-12-15       Impact factor: 6.860

4.  A feasibility study of psychosocial group intervention for breast cancer patients with first recurrence.

Authors:  Masami Chujo; Ichiro Mikami; Shigemitsu Takashima; Toshiaki Saeki; Shozo Ohsumi; Kenjiro Aogi; Hitoshi Okamura
Journal:  Support Care Cancer       Date:  2004-12-03       Impact factor: 3.603

5.  Psychiatric morbidity among Egyptian breast cancer patients and their partners and its impact on surgical decision-making.

Authors:  Mohamed A El-Hadidy; Waleed Elnahas; Mohamed Af Hegazy; Mohamed T Hafez; Basel Refky; Khaled M Abdel Wahab
Journal:  Breast Cancer (Dove Med Press)       Date:  2012-03-06

6.  The value of the Hospital Anxiety and Depression Scale (HADS) for comparing women with early onset breast cancer with population-based reference women.

Authors:  R H Osborne; G R Elsworth; M A G Sprangers; F J Oort; J L Hopper
Journal:  Qual Life Res       Date:  2004-02       Impact factor: 4.147

7.  Prevalence of depression and its related factors among Chinese women with breast cancer.

Authors:  Xiaoli Chen; Ying Zheng; Wei Zheng; Kai Gu; Zhi Chen; Wei Lu; Xiao Ou Shu
Journal:  Acta Oncol       Date:  2009       Impact factor: 4.089

8.  Do rates of mental disorders and existential distress among advanced stage cancer patients increase as death approaches?

Authors:  Wendy G Lichtenthal; Matthew Nilsson; Baohui Zhang; Elizabeth D Trice; David W Kissane; William Breitbart; Holly G Prigerson
Journal:  Psychooncology       Date:  2009-01       Impact factor: 3.894

9.  [Anxiety and depression in cancer patients during the course of radiotherapy treatment].

Authors:  J Maurer; C Schäfer; O Maurer; O Kölbl
Journal:  Strahlenther Onkol       Date:  2012-08-26       Impact factor: 3.621

10.  The Skills of Facilitator Nurses in Psycho-Social Group Intervention for Cancer Patients.

Authors:  Masami Chujo; Hitoshi Okamura
Journal:  Yonago Acta Med       Date:  2015-08-18       Impact factor: 1.641

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.